SightGlass Vision develops innovative technologies and science-based treatments to address the global myopia epidemic, backed by novel and comprehensive research based on the unique contrast theory. Founded in 2016, the company now operates as a joint venture of CooperCompanies and EssilorLuxottica to accelerate commercialization opportunities and expand the myopia management category worldwide.
Understanding DOTâ„¢ Lenses
This course is designed to introduce you to the breakthrough approach to managing childhood myopia, including the theory, science and putting it into practice.